11，Naitoh J, Walzak M P. Hereditary aspects of urologic cancer. Surg Oncol Clin North Am, 1994,3:609～639
22，Sun W H, Burkholder J K, Sun J, et al. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Pric Natl Acad Sci USA, 1995,92:2880～2893
33，Taneja S S, Pierce W, Figlin R, et al. Immunotherapy for renal cell carcinoma: The ear for interleukin based treatment. Urology, 1995,45:911～924
44，Linehan W U, Lerman M I, Zbar B. Identification of the von Hippel-Lindau(VHL) Gene. J Am Assoc, 1995,273:564～570
55，Gnarra J R, Dressler G R. Expression of pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides. Cancer Res, 1995,55:4092～4098
66，Chen F, Kishida T, Duh F M, et al. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res, 1995,55:4804～4807
77，Moon W C, Kim T S, Moon C S. Experimental p53 gene therapy in renal cell carcinoma. J Urol, 1996,155:653A
88，Igarashi T, Marumo K, Onishi T, et al. Interferon-alpha and 5-fluorouracil therapy in patients with metastatic renal cell cancer: An open multicenter trial. Urology, 1999,53:53～59
99，Mike C, Susanne M, Asraham Q, et al. Nonviral inrerferon α gene therapy inhibits growth of established tumors by eliciting a systemic immune response. Hum Gene Ther, 1998,9:2223～2230
1010，Dirk J, Elke J, Sophie C, et al. Strong immunogenic potential of a B7 retroviral expression vector: Generation of HLA-B7-Restricted CTL response against selectable marker genes. Hum Gene Ther, 1998,9:5362
